Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,200
+30 (0.20%)
Apr 16, 2025, 3:30 PM KST
-26.21%
Market Cap 105.93B
Revenue (ttm) 69.02B
Net Income (ttm) 13.09B
Shares Out 6.97M
EPS (ttm) 1,921.00
PE Ratio 7.91
Forward PE n/a
Dividend 1,500.00 (10.05%)
Ex-Dividend Date Dec 27, 2024
Volume 1,437
Average Volume 3,906
Open 15,170
Previous Close 15,170
Day's Range 15,110 - 15,280
52-Week Range 14,500 - 20,450
Beta -0.35
RSI 49.38
Earnings Date Mar 27, 2025

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.